These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 1691679

  • 1. Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.
    Weil-Hillman G, Voss SD, Fisch P, Schell K, Hank JA, Sosman JA, Sugamura K, Sondel PM.
    Cancer Res; 1990 May 01; 50(9):2683-91. PubMed ID: 1691679
    [Abstract] [Full Text] [Related]

  • 2. Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation.
    Harel-Bellan A, Bertoglio J, Quillet A, Marchiol C, Wakasugi H, Mishall Z, Fradelizi D.
    J Immunol; 1986 Apr 01; 136(7):2463-9. PubMed ID: 3005412
    [Abstract] [Full Text] [Related]

  • 3. Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells.
    Baume DM, Robertson MJ, Levine H, Manley TJ, Schow PW, Ritz J.
    Eur J Immunol; 1992 Jan 01; 22(1):1-6. PubMed ID: 1370410
    [Abstract] [Full Text] [Related]

  • 4. Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R, Cassatella MA, Trentin L, Bulian P, Siviero F, Feruglio C, Agostini C, Vespignani M, Chisesi T, Pizzolo G.
    Leukemia; 1991 Nov 01; 5(11):942-50. PubMed ID: 1835747
    [Abstract] [Full Text] [Related]

  • 5. Direct activation of human resting T cells by IL 2: the role of an IL 2 receptor distinct from the Tac protein.
    Bich-Thuy LT, Dukovich M, Peffer NJ, Fauci AS, Kehrl JH, Greene WC.
    J Immunol; 1987 Sep 01; 139(5):1550-6. PubMed ID: 3040856
    [Abstract] [Full Text] [Related]

  • 6. IL-2 receptors on circulating natural killer cells and T lymphocytes. Similarity in number and affinity but difference in transmission of the proliferation signal.
    Ben Aribia MH, Moiré N, Métivier D, Vaquero C, Lantz O, Olive D, Charpentier B, Senik A.
    J Immunol; 1989 Jan 15; 142(2):490-9. PubMed ID: 2783438
    [Abstract] [Full Text] [Related]

  • 7. Involvement of the 55- and 75-kDa tumor necrosis factor receptors in the generation of lymphokine-activated killer cell activity and proliferation of natural killer cells.
    Naume B, Shalaby R, Lesslauer W, Espevik T.
    J Immunol; 1991 May 01; 146(9):3045-8. PubMed ID: 1707931
    [Abstract] [Full Text] [Related]

  • 8. Regulation of CD3- lymphocyte function with an antibody against the IL-2 beta chain receptor: modulation of NK and LAK activity and production of IFN gamma.
    Ortaldo JR, Frey J, Takeshita T, Sugamura K.
    Eur Cytokine Netw; 1990 May 01; 1(1):27-34. PubMed ID: 2151685
    [Abstract] [Full Text] [Related]

  • 9. Synergistic action of monoclonal antibodies directed at p55 and p75 chains of the human IL-2-receptor.
    Audrain M, Boeffard F, Soulillou JP, Jacques Y.
    J Immunol; 1991 Feb 01; 146(3):884-92. PubMed ID: 1988501
    [Abstract] [Full Text] [Related]

  • 10. The multichain interleukin-2 receptor: a target for immunotherapy of patients receiving allografts.
    Waldmann TA, Goldman CK.
    Am J Kidney Dis; 1989 Nov 01; 14(5 Suppl 2):45-53. PubMed ID: 2683757
    [Abstract] [Full Text] [Related]

  • 11. The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferation.
    Waldmann TA, Tsudo M.
    Prog Clin Biol Res; 1988 Nov 01; 262():283-93. PubMed ID: 2897696
    [Abstract] [Full Text] [Related]

  • 12. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells.
    Naume B, Gately M, Espevik T.
    J Immunol; 1992 Apr 15; 148(8):2429-36. PubMed ID: 1373169
    [Abstract] [Full Text] [Related]

  • 13. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
    Fujimiya Y, Suzuki Y, Katakura R, Miyagi T, Yamaguchi T, Yoshimoto T, Ebina T.
    Clin Cancer Res; 1997 Apr 15; 3(4):633-43. PubMed ID: 9815731
    [Abstract] [Full Text] [Related]

  • 14. Induction of proliferation in vitro of resting human natural killer cells: IL 2 induces into cell cycle most peripheral blood NK cells, but only a minor subset of low density T cells.
    London L, Perussia B, Trinchieri G.
    J Immunol; 1986 Dec 15; 137(12):3845-54. PubMed ID: 3491151
    [Abstract] [Full Text] [Related]

  • 15. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-gamma/delta+ T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody.
    Aramburu J, Balboa MA, Ramírez A, Silva A, Acevedo A, Sánchez-Madrid F, De Landázuri MO, López-Botet M.
    J Immunol; 1990 Apr 15; 144(8):3238-47. PubMed ID: 1691231
    [Abstract] [Full Text] [Related]

  • 16. In vitro responsiveness to interleukins and theophylline of CD16+, CD56- natural killer cells in a patient with chronic granular lymphocyte disorder.
    Bayle C, Vitté-Mony I, Lang P, Pico J, Hercend T, Bertoglio J.
    Leukemia; 1992 May 15; 6(5):470-6. PubMed ID: 1375700
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of lymphokine-activated killer cells by human pulmonary macrophages: discordance between up-regulation of the beta chain (p75) of the interleukin-2 receptor on CD56+ cells and limited response to interleukin-2.
    Yarbrough WC, Wilkes DS, Weissler JC.
    Am J Respir Cell Mol Biol; 1994 Feb 15; 10(2):184-91. PubMed ID: 7509162
    [Abstract] [Full Text] [Related]

  • 18. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE, Herring B, Wilson LA, Rickford MS, Zhang M, Goldman CK, Tso JY, Waldmann TA.
    Cancer Res; 2000 Dec 15; 60(24):6977-84. PubMed ID: 11156399
    [Abstract] [Full Text] [Related]

  • 19. Role of interleukin 2 receptor beta chain in initiating anti-CD3 and interleukin 2-induced proliferation of human resting T cells.
    Moiré N, Calvo CF, Métivier D, Perrot JY, Vaquero C, Hatakeyama M, Senik A.
    Eur J Immunol; 1990 Sep 15; 20(9):1981-7. PubMed ID: 2145171
    [Abstract] [Full Text] [Related]

  • 20. The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.
    Schmidt RE, Hercend T, Fox DA, Bensussan A, Bartley G, Daley JF, Schlossman SF, Reinherz EL, Ritz J.
    J Immunol; 1985 Jul 15; 135(1):672-8. PubMed ID: 3923116
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.